Navigation Links
Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
Date:8/19/2007

Oncomine and Oncomine Concepts Map Integral in Expression and Association

Analyses

ANN ARBOR, Mich., Aug. 2 /PRNewswire/ -- Building on an earlier study that used Oncomine(TM) to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. today report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070213/NYTU093LOGO )

Tomlins et al. queried the Oncomine database to determine the tissue specificity of three of the new fusion gene partners, demonstrating that two new partners are prostate cancer specific while the third partner is a generally over-expressed 'house-keeping' gene. In addition, Oncomine Concepts Map was applied to test for similarities between the set of genes regulated by ETV1 with sets of genes related to other biological concepts. This analysis revealed a clear association between ETV1 activation and cellular invasion, a hallmark of cancer.

Oncomine, a dynamic repository that combines rich data, sophisticated analysis, and responsive user interface, empowers oncology research by bringing data analysis tools to a large cancer gene expression database, which includes data from 20,000+ microarray experiments curated from 300+ independent studies. Oncomine Concepts Map, an extension of Oncomine, is a compilation of nearly 8,000 Oncomine cancer gene signatures together with 11,500 gene, protein, drug, and pathway signatures collected from the literature and other public sources.

"This study marks an important advance in our understanding of the molecular basis of prostate cancer. Oncomine again proved invaluable in examining the expression of genes in cancer, and in this case aided in the characterization of n
'/>"/>

SOURCE Compendia Bioscience, Inc.

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
2. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
3. Protox Announces Positive Clinical Data from Prostate Cancer Study
4. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
5. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
6. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
7. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
8. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
9. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
10. Quest PharmaTechs Prostate Cancer Program Update
11. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHo...followinganautoaccident,wasactuallyfullyconsciousa...gAmericasegment.TheDynaVoxEyeMaxwasfeaturedinthese...otherconditionscanunlockcommunication. ,, WHEN:...nlineat www.dynavoxtech.com ,, WHO:RomHo...
(Date:11/24/2009)..., FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Ver...mpanyfileditsPlanofReorganizationandDisclosureStat...ruptcyCourtfortheDistrictofDelaware.Ahearingtocons...eduledforDecember8,2009,withthehearingontheconfirm...PlancallsfortheCompanytopayallclaimsinfull.ThePlan...
(Date:11/24/2009)..., POTOMAC,Md.,Nov.24/PRNewswire/--Inadditiontofami...addedPhiladelphiajurorstoherThanksgivinggratitudel...Iamsothankfultothem,"shesaidofMonday,sverdictstota...s. ,, Wisneskiisamong12,000womennationwidewhoha...monetherapydrugsPremarinandPrempro.Wisneskiandtheo...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 1iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 2iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 3iHealthSpot Inc Named Winner in the 2009 STEVIE 26apos 3B AWARDS 28American Business Awards 29 50003 4SensoTech Awarded Wireless Temperature Monitoring Contract By Amerinet 50000 1SensoTech Awarded Wireless Temperature Monitoring Contract By Amerinet 50000 2Top Dentist Issues Opinion on Health Benefits of Cutting Edge Orthodontics 49997 1Top Dentist Issues Opinion on Health Benefits of Cutting Edge Orthodontics 49997 2
..., LAUSANNE, Switzerland, April 28 Debiopharm ...elopment specialist that focuses,on serious medica...y,presented results from a phase IIa study with De...ith a potent anti-hepatitis C (HCV) effect.,Reveal...ciation for the Study,of the Liver, in Copenhagen,...
..., LINTHICUM, Md., April 27 Men taking generic dru...ts and more adverse events than if they were using...esearchers in New York. Researchers presented a st...American Urological Association (AUA) showing that...a reductase inhibitors (5-ARIs), two classes of me...
Other Medicine Technology:Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms 2
(Date:11/25/2009)...nn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopleh...practorcanalsogivepatientsthehelptheyneed.TMJstand...w(mandible)contacts/connectswithyourskull(temporal...Jdysfunctionarepainwithchewing,clickingorpoppingof...nctionincluding:headaches,fatigue,sleepdisturbance...
(Date:11/25/2009)...H,Calif.,Nov.25/PRNewswire/--Thanksgivingmealswill...hegreaterLongBeachareathankstoFaithInAction/Volunt...Home(IAH),adivisionofSCANHealthPlan.Formorethan17y...eerstodeliverwarmThanksgivingmealstoseniorsinneedi...gelesandsurroundingcities. ,, "Ourwarmholidayme...
(Date:11/25/2009)...ivors of testicular cancer who were treated with c...ffects, including neurological side effects and Ra...d with chemotherapy, according to a new study publ...tional Cancer Institute . , Marianne Brydy, M.D....ity Hospital, in Bergen, Norway, and colleagues co...
(Date:11/25/2009)...dy used to fight rheumatoid arthritis, could help ..., WEDNESDAY, Nov. 25 (HealthDay News) -- A drug c...heumatoid arthritis now also shows some promise in...etes. , The drug, rituximab (Rituxan), helped p...even though the disease had destroyed some of thei...
(Date:11/25/2009)...Nov.25/PRNewswire/-- MISSIONSkincare ®isproud....Jude.AspartofGNC,sannualSt.Jude ThanksandGiving c...are,s new SUPER-C(TM)LipBalm willbedonatedtoSt.J...akea$1,$5or$10donationatcheckoutatoneoftheir5,000+...$1millionforSt.Judeduringtheir2009 ThanksandGiving...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...ased in the Northeast region with more hires,plann...RISBURG, Pa., Aug. 28 The Pennsylvania,Patient Sa...for the,Northeast region to help healthcare facili... groups with Pennsylvania Patient Safety Officers,...
... Leading dermatology company serves growing profe... Palo Alto, CA (PRWEB) August 28, 2...apital firm, today announced that together with Mu...ly invested $15.5 million in the round. Profex, a ...
...y, not injury itself, associated with increased pl...) -- A group of researchers has described hourly c...o play a key role in Alzheimer,s disease. , In a ...ll communication increased, so did amyloid beta. W...
... The Accreditation Council for Continuing Medical...ion of the College of American Pathologists (CAP) ... provider of continuing medical education for phys...arded the Education Division of the www.cap.org ...
... Leading personal injury law firm files notice of...Police Department. , Mine...hesandersfirm.com/attorney.asp?attorneyid=14 [Mar... York, today announced that his firm has filed a N...
...7 Replidyne, Inc.,(Nasdaq: RDYN ) today announce... current employee headcount by approximately 80% t...e place during September 2008 and October,2008. As...m difficile (C. difficile) bacteria and C. diffici...
Other Medicine News:Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 3Health News:Scientists Track Hourly Changes in Alzheimer's Protein 2Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:Replidyne Announces Restructuring of Operations 2
Tipack (Sterilized) DL10
Tipack (Sterilized) D10
10 L Pipette Tip (RNase, DNase and pyrogen free)
ART 300 Multi-Channel
Medicine Products: